Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00241826 · ClinicalTrials.gov registry record
Prospective Investigation of Pulmonary Embolism Diagnosis III
A clinical trial of Pulmonary Embolism and Lung Diseases, sponsored by George Washington University.
- Completed
- Registry status
- 1,256
- Enrollment target
- 9
- Study locations
NCT00241826: Completed study of Pulmonary Embolism and Lung Diseases, sponsored by George Washington University.
NCT00241826 is a study of Pulmonary Embolism and Lung Diseases that has completed, run by George Washington University. The registered enrollment target is 1,256 participants, below the 3,032-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (59% lower). The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00241826, a study of Pulmonary Embolism and Lung Diseases, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- 1,256 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this study is to determine the diagnostic accuracy of gadolinium-enhanced magnetic resonance angiography (Gd-MRA) of the pulmonary arteries in combination with magnetic resonance venography (MRV) of the veins of the thighs in patients with clinically suspected acute pulmonary embolism (PE).
Conditions Studied
Interventions
- PROCEDURE Magnetic Resonance Angiography
- PROCEDURE Magnetic Resonance Venography
Study Locations (9)
Maryland
- Divison of Lung Diseases, NHLBI - Bethesda
- Data Coordinating Center - Rockville
Michigan
- University of Michigan Medical Center - Ann Arbor
- St. Joseph Mercy-Oakland - Pontiac
Georgia
- Emory University - Atlanta
Massachusetts
- Massachusetts General Hospital - Boston
Missouri
- Washington University Medical Center - St Louis
New York
- NYU Medical Center - New York
Alberta
- Foothills Hospital - Calgary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,256 participants |
| Start Date | 2006-04 |
| Est. Completion | 2009-04 |
What the finished NCT00241826 record still lists
NCT00241826 is an observational study that tracks outcomes without assigning an intervention. Its 1,256 participants enrollment target places it among the larger protocols in the corpus, below the 3,032-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (59% lower).
The record links to 2 conditions, with Pulmonary Embolism appearing as the primary indexed condition, and to 2 interventions - of which Magnetic Resonance Angiography is the first listed.
NCT00241826 lists 9 locations in 7 states (Maryland, Michigan, Georgia).
Frequently Asked Questions
What is clinical trial NCT00241826 about?
NCT00241826 is a clinical study titled "Prospective Investigation of Pulmonary Embolism Diagnosis III". The purpose of this study is to determine the diagnostic accuracy of gadolinium-enhanced magnetic resonance angiography (Gd-MRA) of the pulmonary arteries in combination with magnetic resonance venography (MRV) of the veins of the thighs in patients with clinically suspected acute pulmonary embolism...
What is the current status of trial NCT00241826?
This trial is currently completed. The enrollment target is 1,256 participants. The study started on 2006-04. Estimated completion is 2009-04.
What conditions does trial NCT00241826 study?
This clinical trial studies the following conditions: Pulmonary Embolism, Lung Diseases.
What interventions are being tested in trial NCT00241826?
The interventions under investigation include: Magnetic Resonance Angiography (PROCEDURE), Magnetic Resonance Venography (PROCEDURE).
Who is sponsoring clinical trial NCT00241826?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00241826 being conducted?
This trial has 9 study locations across Georgia, Maryland, Massachusetts, Michigan, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00241826's enrollment target sits among peer trials
1,256 6th of 48 higher than 43 of 48 other Pulmonary Embolism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Embolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The PERSEVERE Study
RECRUITING · NA
-
Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
RECRUITING
-
Supplemental Oxygen in Pulmonary Embolism (SO-PE)
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06712316 · 1,260 participants · Phase 2
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- NCT06812273 · 1,260 participants · NA
Mediators and Moderators of Auditory Training
- NCT06931340 · 1,260 participants · Phase 3
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- NCT02743858 · 1,250 participants
Lymphedema Surveillance Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia